8U4E image
Entry Detail
PDB ID:
8U4E
EMDB ID:
Title:
Cryo-EM structure of long form insulin receptor (IR-B) with three IGF2 bound, asymmetric conformation.
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-09-10
Release Date:
2024-03-27
Method Details:
Experimental Method:
Resolution:
4.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Insulin receptor
Chain IDs:A, B
Chain Length:1382
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Insulin-like growth factor II
Chain IDs:C, D, E
Chain Length:180
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Activation of the insulin receptor by insulin-like growth factor 2.
Nat Commun 15 2609 2609 (2024)
PMID: 38521788 DOI: 10.1038/s41467-024-46990-6

Abstact

Insulin receptor (IR) controls growth and metabolism. Insulin-like growth factor 2 (IGF2) has different binding properties on two IR isoforms, mimicking insulin's function. However, the molecular mechanism underlying IGF2-induced IR activation remains unclear. Here, we present cryo-EM structures of full-length human long isoform IR (IR-B) in both the inactive and IGF2-bound active states, and short isoform IR (IR-A) in the IGF2-bound active state. Under saturated IGF2 concentrations, both the IR-A and IR-B adopt predominantly asymmetric conformations with two or three IGF2s bound at site-1 and site-2, which differs from that insulin saturated IR forms an exclusively T-shaped symmetric conformation. IGF2 exhibits a relatively weak binding to IR site-2 compared to insulin, making it less potent in promoting full IR activation. Cell-based experiments validated the functional importance of IGF2 binding to two distinct binding sites in optimal IR signaling and trafficking. In the inactive state, the C-terminus of α-CT of IR-B contacts FnIII-2 domain of the same protomer, hindering its threading into the C-loop of IGF2, thus reducing the association rate of IGF2 with IR-B. Collectively, our studies demonstrate the activation mechanism of IR by IGF2 and reveal the molecular basis underlying the different affinity of IGF2 to IR-A and IR-B.

Legend

Protein

Chemical

Disease

Primary Citation of related structures